David H Volle

Dr. David H Volle

Inserm U1103, Université Clermont Auvergne, CNRS UMR-6293, GReD, F-63001 Clermont-Ferrand, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Molecular Aspects of Medicine
Verified
Journal Article
Closed access
EMEmmanuelle Martinot
Emmanuelle Martinot
LSLauriane Sèdes
Lauriane Sèdes
MBMarine Baptissart
Marine Baptissart
JLJean-Marc Lobaccaro
Jean-Marc Lobaccaro
FCFrançoise Caira
Françoise Caira
DVDavid H Volle
David H Volle

19 July 2018 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
LSLauriane Sèdes
Lauriane Sèdes
LTLaura Thirouard
Laura Thirouard
SMSalwan Maqdasy
Salwan Maqdasy
MGManon Garcia
Manon Garcia
FCFrançoise Caira
Françoise Caira
DVDavid H Volle
David H Volle
Cholesterol is essential for mammalian cell functions and integrity. It is an important structural component maintaining the permeability and fluidity of the cell membrane. The balance between synthesis and catabolism of cholesterol should be tightly regulated to ensure normal cellular processes. Male reproductive function has been demonstrated to be dependent on cholesterol homeostasis. Here we review data highlighting the impacts of cholesterol homeostasis on male fertility and the molecular mechanisms implicated through the signaling pathways of some nuclear receptors.

1 December 2009 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DVDavid H Volle
David H Volle
MDMélanie Decourteix
Mélanie Decourteix
EGErwan Garo
Erwan Garo
JMJudy McNeilly
Judy McNeilly
PFPatrick Fenichel
Patrick Fenichel
MBMohamed Benahmed
Mohamed Benahmed
Studies in rodents have shown that male sexual function can be disrupted by fetal or neonatal administration of compounds that alter endocrine homeostasis, such as the synthetic nonsteroidal estrogen diethylstilbestrol (DES). Although the molecular basis for this effect remains unknown, estrogen receptors likely play a critical role in mediating DES-induced infertility. Recently, we showed that the orphan nuclear receptor small heterodimer partner (Nr0b2), which is both a target gene and a transcriptional repressor of estrogen receptors, controls testicular function by regulating germ cell entry into meiosis and testosterone synthesis. We therefore hypothesized that some of the harmful effects of DES on testes could be mediated through Nr0b2. Here, we present data demonstrating that Nr0b2 deficiency protected mice against the negative effects of DES on testis development and function. During postnatal development, Nr0b2-null mice were resistant to DES-mediated inhibition of germ cell differentiation, which may be the result of interference by Nr0b2 with retinoid signals that control meiosis. Adult Nr0b2-null male mice were also protected against the effects of DES; however, we suggest that this phenomenon was due to the removal of the repressive effects of Nr0b2 on steroidogenesis. Together, these data demonstrate that Nr0b2 plays a critical role in the pathophysiological changes induced by DES in the mouse testis.

3 May 2014 in Hepatology
Verified
Journal Article
Open access
PDF file
MBMarine Baptissart
Marine Baptissart
AVAurélie Vega
Aurélie Vega
EMEmmanuelle Martinot
Emmanuelle Martinot
APAurélien J. Pommier
Aurélien J. Pommier
SHSander Michel Houten
Sander Michel Houten
DVDavid H Volle
David H Volle
Bile acids (BAs) are signaling molecules that are involved in many physiological functions, such as glucose and energy metabolism. These effects are mediated through activation of the nuclear and membrane receptors, farnesoid X receptor (FXR-α) and TGR5 (G-protein-coupled bile acid receptor 1; GPBAR1). Although both receptors are expressed within the testes, the potential effect of BAs on testis physiology and male fertility has not been explored thus far. Here, we demonstrate that mice fed a diet supplemented with cholic acid have reduced fertility subsequent to testicular defects. Initially, germ cell sloughing and rupture of the blood-testis barrier occur and are correlated with decreased protein accumulation of connexin-43 (Cx43) and N-cadherin, whereas at later stages, apoptosis of spermatids is observed. These abnormalities are associated with increased intratesticular BA levels in general and deoxycholic acid, a TGR5 agonist, in particular. We demonstrate here that Tgr5 is expressed within the germ cell lineage, where it represses Cx43 expression through regulation of the transcriptional repressor, T-box transcription factor 2 gene. Consistent with this finding, mice deficient for Tgr5 are protected against the deleterious testicular effects of BA exposure. Conclusions: These data identify the testis as a new target of BAs and emphasize TGR5 as a critical element in testicular pathophysiology. This work may open new perspectives on the potential effect of BAs on testis physiology during liver dysfunction. (Hepatology 2014;60:1054-1065)

Verified
Journal Article
Open access
PDF file
MGManon Garcia
Manon Garcia
LTLaura Thirouard
Laura Thirouard
LSLauriane Sedès
Lauriane Sedès
MMMélusine Monrose
Mélusine Monrose
HHHélène Holota
Hélène Holota
CBClaude Beaudoin
Claude Beaudoin
Structural and functional studies have provided numerous insights over the past years on how members of the nuclear hormone receptor superfamily tightly regulate the expression of drug-metabolizing enzymes and transporters. Besides the role of the farnesoid X receptor (FXR) in the transcriptional control of bile acid transport and metabolism, this review provides an overview on how this metabolic sensor prevents the accumulation of toxic byproducts derived from endogenous metabolites, as well as of exogenous chemicals, in coordination with the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR). Decrypting this network should provide cues to better understand how these metabolic nuclear receptors participate in physiologic and pathologic processes with potential validation as therapeutic targets in human disabilities and cancers.

3 February 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
MBMarine Baptissart
Marine Baptissart
EMEmmanuelle Martinot
Emmanuelle Martinot
AVAurélie Vega
Aurélie Vega
LSLauriane Sédes
Lauriane Sédes
BRBetty Rouaisnel
Betty Rouaisnel
DVDavid H Volle
David H Volle
Bile acid-FXRα pathways regulate male sexual maturation in mice